Hepatitis C

Showing NaN - NaN of 107

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated interferon alfa 2a)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +61 more
Jul 9, 2014

Hepatitis C Trial in Worldwide (Telaprevir, Ribavirin, Pegylated Interferon Alfa 2a)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +52 more
Jul 9, 2014

Hepatitis C Trial in Worldwide (TMC435, Ribavirin (R), PegIFNa-2a (P))

Completed
  • Hepatitis C
  • Los Angeles, California
  • +72 more
May 19, 2014

Hepatitis C Trial in Worldwide (TMC435, Placebo, Peg-IFN-alfa-2a (P))

Completed
  • Hepatitis C
  • La Jolla, California
  • +80 more
May 30, 2014

Hepatitis C Trial in Worldwide (Placebo, TMC435, Peginterferon alpha-2a (PegIFN alpha-2a))

Completed
  • Hepatitis C
  • Placebo
  • +3 more
  • Dothan, Alabama
  • +62 more
May 20, 2014

Hepatitis C Trial in Worldwide (Sofosbuvir, PEG, RBV)

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +96 more
Mar 4, 2014

Hepatitis C, Thalassemia Trial in Canada, United Kingdom, United States (Peginterferon Alfa-2a and Ribavirin, Ribavirin)

Completed
  • Hepatitis C
  • Thalassemia
  • Oakland, California
  • +4 more
Mar 3, 2014

Subjects Previously Treated With Telaprevir

Completed
  • Hepatitis C
  • Birmingham, Alabama
  • +40 more
Feb 26, 2014

Hepatitis, Hepatitis C Trial in Worldwide (Filibuvir, Placebo)

Completed
  • Hepatitis
  • Hepatitis C
  • Anaheim, California
  • +76 more
Dec 10, 2013

Hepatitis C, HIV Trial in Worldwide (telaprevir or matching , peginterferon alfa-2a, ribavirin (fixed dose))

Completed
  • Hepatitis C
  • HIV Infections
  • telaprevir or matching placebo
  • +3 more
  • Beverly Hills, California
  • +15 more
Aug 2, 2013

Hepatitis C Trial in Puerto Rico, United States (PF-00868554, Placebo)

Completed
  • Hepatitis C
  • La Jolla, California
  • +9 more
Jun 18, 2013

Hepatitis C Trial in Puerto Rico, United States (Single Ascending Dose Cohorts GS-9620, Multiple Ascending Dose Cohorts GS-9620)

Completed
  • Hepatitis C
  • Single Ascending Dose Cohorts GS-9620
  • Multiple Ascending Dose Cohorts GS-9620
  • Little Rock, Arkansas
  • +10 more
Aug 12, 2013

Characterization of Clonal B Cell Populations in HCV Infection

Completed
  • Hepatitis C
    • New York, New York
    • +1 more
    Aug 6, 2013

    Hepatitis C Trial in United States (LADR Treatment)

    Completed
    • Hepatitis C
    • LADR Treatment
    • Los Angeles, California
    • +7 more
    Apr 11, 2013

    Hepatitis C Trial in Puerto Rico, United States (Peg-Intron, REBETOL, HCV 796)

    Completed
    • Hepatitis C
    • Anaheim, California
    • +34 more
    Feb 7, 2013

    Hepatitis C Virus Infection in HIV-Infected Children

    Completed
    • HIV Infections
    • Hepatitis C
      • Birmingham, Alabama
      • +38 more
      Oct 30, 2012

      HIV, Hepatitis C Trial in United States (Peer Education Intervention)

      Completed
      • HIV Infections
      • Hepatitis C
      • Peer Education Intervention
      • Los Angeles, California
      • +4 more
      Sep 26, 2012

      Hepatitis C Trial in United States (CTS-1027, pegylated interferon, Ribavirin)

      Terminated
      • Hepatitis C
      • Birmingham, Alabama
      • +44 more
      Jun 4, 2012

      Hepatitis C, Chronic, Hepatitis C, Thrombocytopenia Trial in Worldwide (SB497115, Placebo)

      Completed
      • Hepatitis C, Chronic
      • +2 more
      • Denver, Colorado
      • +29 more
      May 31, 2012

      HIV, Hepatitis C Trial in Los Angeles, Indianapolis, New York (Interferon alfa-2b, Zidovudine, Zalcitabine)

      Completed
      • HIV Infections
      • Hepatitis C
      • Interferon alfa-2b
      • +3 more
      • Los Angeles, California
      • +2 more
      Apr 27, 2012

      HIV, Hepatitis C Trial in New York (Silymarin, Placebo)

      Completed
      • HIV Infections
      • Hepatitis C
      • New York, New York
        Mount Sinai School of Medicine
      Sep 14, 2011

      Hepatitis C, Depressive Disorder, Major, Depressive Disorder Trial in New York (Hepatitis C educational support groups,

      Terminated
      • Hepatitis C
      • +4 more
      • Hepatitis C educational support groups
      • Cognitive Behavioral Therapy skills based group sessions
      • New York, New York
        Mount Sinai School of Medicine
      Aug 5, 2011

      Study of the Immune Response to Hepatitis C Virus

      Completed
      • Hepatitis C
        • New York, New York
          Rockefeller University Hospital
        Dec 9, 2010

        Hepatic Encephalopathy, Hepatitis C, Liver Cirrhosis Trial in New York (Rifaximin (drug))

        Unknown status
        • Hepatic Encephalopathy
        • +2 more
        • Rifaximin (drug)
        • New York, New York
          New York Presbyterian Hospital: Weill Medical College of Cornell
        Nov 4, 2010

        Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis

        Completed
        • HIV Infections
        • Hepatitis C
          • Los Angeles, California
          • +42 more
          Jul 30, 2008